Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LW402 in Non-Segmental Vitiligo
NCT07556471Phase 2Not yet recruiting
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Start
- May 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lw402 in Vitiligo, sponsored by Shanghai Longwood Biopharmaceuticals Co., Ltd.. Planned start May 2026; status: not yet recruiting.
02
Drugs
lw402
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07556471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07556471.